Michele Annette Glinn

Title: Michele Annette Glinn: Innovator in Acetylcholine Research

Introduction

Michele Annette Glinn is a prominent inventor based in Okemos, MI (US). She has made significant contributions to the field of neuroscience, particularly in the area of acetylcholine research. With a total of two patents to her name, her work focuses on methods to enhance acetylcholine levels, which is crucial for various neurological functions.

Latest Patents

Michele's latest patents include innovative methods for increasing levels of acetylcholine. The first patent is directed to increasing levels of acetylcholine by the administration of 2-aryl-3-aroylbenzo[b]thiophenes. The second patent relates to a method for increasing levels of acetylcholine by administering an effective amount of a compound of formula (I), along with an optional AChE inhibitor. These inventions hold promise for therapeutic applications in treating conditions related to acetylcholine deficiency.

Career Highlights

Michele is currently associated with Eli Lilly and Company, where she continues to advance her research in pharmacology and neuroscience. Her work has been instrumental in developing new therapeutic strategies that target acetylcholine levels, contributing to the understanding of various neurological disorders.

Collaborations

Michele has collaborated with notable colleagues, including Henry U Bryant and Steven Marc Paul. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in her field.

Conclusion

Michele Annette Glinn's contributions to acetylcholine research exemplify her dedication to advancing scientific knowledge and therapeutic solutions. Her innovative patents and collaborations highlight her role as a leading inventor in the field.